Jubilant Biosys Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CARBAMAZEPINE USP, with a corresponding US DMF Number 14410.
Remarkably, this DMF maintains an Active status since its submission on September 21, 1999, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 01, 2014, and payment made on July 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II